カテゴリ： 世界, 医療/バイオ, QYResearch

自家生物製剤の世界市場2023年：脂肪組織、血漿、その他

■ 英語タイトル：Global Autologous Biologics Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7646）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7646
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[自家生物製剤の世界市場2023年：脂肪組織、血漿、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は自家生物製剤のグローバル市場について調査・分析し、世界の自家生物製剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（脂肪組織、血漿、その他）、用途別セグメント分析（病院、外来センター、研究センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Vericel Corporation、BioTime, Inc.、Pharmicell Co.、BrainStorm Cell Therapeutics、Opexa Therapeutics, Inc、Pharmicell Co., Inc、Neostem、Dendreon Corporation、Regenexx、Cytori Therapeuticsなどが含まれています。自家生物製剤のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、自家生物製剤市場規模を算出する際に考慮しました。

・自家生物製剤市場の概要
- 製品の定義
- 自家生物製剤の種類別セグメント
- 世界の自家生物製剤市場規模：タイプ別分析（脂肪組織、血漿、その他）
- 自家生物製剤の用途別セグメント
- 世界の自家生物製剤市場規模：用途別分析（病院、外来センター、研究センター）
- 世界の自家生物製剤市場規模予測（2018年-2029年）
- 自家生物製剤の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 自家生物製剤市場の競争状況およびトレンド

・自家生物製剤の地域別市場規模
- 北米の自家生物製剤市場規模（2018年-2029年）
- 米国の自家生物製剤市場規模（2018年-2029年）
- ヨーロッパの自家生物製剤市場規模（2018年-2029年）
- アジア太平洋の自家生物製剤市場規模（2018年-2029年）
- 中国の自家生物製剤市場規模（2018年-2029年）
- 日本の自家生物製剤市場規模（2018年-2029年）
- 韓国の自家生物製剤市場規模（2018年-2029年）
- インドの自家生物製剤市場規模（2018年-2029年）
- オーストラリアの自家生物製剤市場規模（2018年-2029年）
- 中南米の自家生物製剤市場規模（2018年-2029年）
- 中東・アフリカの自家生物製剤市場規模（2018年-2029年）

・種類別セグメント：脂肪組織、血漿、その他
- 世界の自家生物製剤のタイプ別販売量（2018年-2023年）
- 世界の自家生物製剤のタイプ別売上（2018年-2023年）
- 世界の自家生物製剤のタイプ別価格

・用途別セグメント：病院、外来センター、研究センター
- 世界の自家生物製剤の用途別販売量（2018年-2023年）
- 世界の自家生物製剤の用途別売上（2018年-2023年）
- 世界の自家生物製剤の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Vericel Corporation、BioTime, Inc.、Pharmicell Co.、BrainStorm Cell Therapeutics、Opexa Therapeutics, Inc、Pharmicell Co., Inc、Neostem、Dendreon Corporation、Regenexx、Cytori Therapeutics

・産業チェーンと販売チャネルの分析
- 自家生物製剤産業チェーン分析
- 自家生物製剤の主要原材料
- 自家生物製剤の販売チャネル
- 自家生物製剤のディストリビューター
- 自家生物製剤の主要顧客

・自家生物製剤市場ダイナミクス
- 自家生物製剤の業界動向
- 自家生物製剤市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Autologous Biologics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Autologous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Autologous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Autologous Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Biologics.
The Autologous Biologics market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Autologous Biologics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Vericel Corporation
BioTime, Inc.
Pharmicell Co.
BrainStorm Cell Therapeutics
Opexa Therapeutics, Inc
Pharmicell Co., Inc
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
Segment by Type
Adipose Tissue
Plasma
Others
Segment by Application
Hospitals
Ambulatory Centers
Research Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autologous Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autologous Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Autologous Biologics Market Overview
1.1 Product Overview and Scope of Autologous Biologics
1.2 Autologous Biologics Segment by Type
1.2.1 Global Autologous Biologics Market Value Comparison by Type (2023-2029)
1.2.2 Adipose Tissue
1.2.3 Plasma
1.2.4 Others
1.3 Autologous Biologics Segment by Application
1.3.1 Global Autologous Biologics Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Ambulatory Centers
1.3.4 Research Centers
1.4 Global Autologous Biologics Market Size Estimates and Forecasts
1.4.1 Global Autologous Biologics Revenue 2018-2029
1.4.2 Global Autologous Biologics Sales 2018-2029
1.4.3 Global Autologous Biologics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Autologous Biologics Market Competition by Manufacturers
2.1 Global Autologous Biologics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Autologous Biologics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Autologous Biologics Average Price by Manufacturers (2018-2023)
2.4 Global Autologous Biologics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Autologous Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autologous Biologics, Product Type & Application
2.7 Autologous Biologics Market Competitive Situation and Trends
2.7.1 Autologous Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autologous Biologics Players Market Share by Revenue
2.7.3 Global Autologous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autologous Biologics Retrospective Market Scenario by Region
3.1 Global Autologous Biologics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Autologous Biologics Global Autologous Biologics Sales by Region: 2018-2029
3.2.1 Global Autologous Biologics Sales by Region: 2018-2023
3.2.2 Global Autologous Biologics Sales by Region: 2024-2029
3.3 Global Autologous Biologics Global Autologous Biologics Revenue by Region: 2018-2029
3.3.1 Global Autologous Biologics Revenue by Region: 2018-2023
3.3.2 Global Autologous Biologics Revenue by Region: 2024-2029
3.4 North America Autologous Biologics Market Facts & Figures by Country
3.4.1 North America Autologous Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Autologous Biologics Sales by Country (2018-2029)
3.4.3 North America Autologous Biologics Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autologous Biologics Market Facts & Figures by Country
3.5.1 Europe Autologous Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Autologous Biologics Sales by Country (2018-2029)
3.5.3 Europe Autologous Biologics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autologous Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Autologous Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Autologous Biologics Sales by Country (2018-2029)
3.6.3 Asia Pacific Autologous Biologics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Autologous Biologics Market Facts & Figures by Country
3.7.1 Latin America Autologous Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Autologous Biologics Sales by Country (2018-2029)
3.7.3 Latin America Autologous Biologics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autologous Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Autologous Biologics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Autologous Biologics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Autologous Biologics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autologous Biologics Sales by Type (2018-2029)
4.1.1 Global Autologous Biologics Sales by Type (2018-2023)
4.1.2 Global Autologous Biologics Sales by Type (2024-2029)
4.1.3 Global Autologous Biologics Sales Market Share by Type (2018-2029)
4.2 Global Autologous Biologics Revenue by Type (2018-2029)
4.2.1 Global Autologous Biologics Revenue by Type (2018-2023)
4.2.2 Global Autologous Biologics Revenue by Type (2024-2029)
4.2.3 Global Autologous Biologics Revenue Market Share by Type (2018-2029)
4.3 Global Autologous Biologics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Autologous Biologics Sales by Application (2018-2029)
5.1.1 Global Autologous Biologics Sales by Application (2018-2023)
5.1.2 Global Autologous Biologics Sales by Application (2024-2029)
5.1.3 Global Autologous Biologics Sales Market Share by Application (2018-2029)
5.2 Global Autologous Biologics Revenue by Application (2018-2029)
5.2.1 Global Autologous Biologics Revenue by Application (2018-2023)
5.2.2 Global Autologous Biologics Revenue by Application (2024-2029)
5.2.3 Global Autologous Biologics Revenue Market Share by Application (2018-2029)
5.3 Global Autologous Biologics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Vericel Corporation
6.1.1 Vericel Corporation Corporation Information
6.1.2 Vericel Corporation Description and Business Overview
6.1.3 Vericel Corporation Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Vericel Corporation Autologous Biologics Product Portfolio
6.1.5 Vericel Corporation Recent Developments/Updates
6.2 BioTime, Inc.
6.2.1 BioTime, Inc. Corporation Information
6.2.2 BioTime, Inc. Description and Business Overview
6.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BioTime, Inc. Autologous Biologics Product Portfolio
6.2.5 BioTime, Inc. Recent Developments/Updates
6.3 Pharmicell Co.
6.3.1 Pharmicell Co. Corporation Information
6.3.2 Pharmicell Co. Description and Business Overview
6.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pharmicell Co. Autologous Biologics Product Portfolio
6.3.5 Pharmicell Co. Recent Developments/Updates
6.4 BrainStorm Cell Therapeutics
6.4.1 BrainStorm Cell Therapeutics Corporation Information
6.4.2 BrainStorm Cell Therapeutics Description and Business Overview
6.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BrainStorm Cell Therapeutics Autologous Biologics Product Portfolio
6.4.5 BrainStorm Cell Therapeutics Recent Developments/Updates
6.5 Opexa Therapeutics, Inc
6.5.1 Opexa Therapeutics, Inc Corporation Information
6.5.2 Opexa Therapeutics, Inc Description and Business Overview
6.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Opexa Therapeutics, Inc Autologous Biologics Product Portfolio
6.5.5 Opexa Therapeutics, Inc Recent Developments/Updates
6.6 Pharmicell Co., Inc
6.6.1 Pharmicell Co., Inc Corporation Information
6.6.2 Pharmicell Co., Inc Description and Business Overview
6.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pharmicell Co., Inc Autologous Biologics Product Portfolio
6.6.5 Pharmicell Co., Inc Recent Developments/Updates
6.7 Neostem
6.6.1 Neostem Corporation Information
6.6.2 Neostem Description and Business Overview
6.6.3 Neostem Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Neostem Autologous Biologics Product Portfolio
6.7.5 Neostem Recent Developments/Updates
6.8 Dendreon Corporation
6.8.1 Dendreon Corporation Corporation Information
6.8.2 Dendreon Corporation Description and Business Overview
6.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dendreon Corporation Autologous Biologics Product Portfolio
6.8.5 Dendreon Corporation Recent Developments/Updates
6.9 Regenexx
6.9.1 Regenexx Corporation Information
6.9.2 Regenexx Description and Business Overview
6.9.3 Regenexx Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Regenexx Autologous Biologics Product Portfolio
6.9.5 Regenexx Recent Developments/Updates
6.10 Cytori Therapeutics
6.10.1 Cytori Therapeutics Corporation Information
6.10.2 Cytori Therapeutics Description and Business Overview
6.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cytori Therapeutics Autologous Biologics Product Portfolio
6.10.5 Cytori Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autologous Biologics Industry Chain Analysis
7.2 Autologous Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autologous Biologics Production Mode & Process
7.4 Autologous Biologics Sales and Marketing
7.4.1 Autologous Biologics Sales Channels
7.4.2 Autologous Biologics Distributors
7.5 Autologous Biologics Customers
8 Autologous Biologics Market Dynamics
8.1 Autologous Biologics Industry Trends
8.2 Autologous Biologics Market Drivers
8.3 Autologous Biologics Market Challenges
8.4 Autologous Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Autologous Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Autologous Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Autologous Biologics Market Competitive Situation by Manufacturers in 2022
Table 4. Global Autologous Biologics Sales (Kg) of Key Manufacturers (2018-2023)
Table 5. Global Autologous Biologics Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Autologous Biologics Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Autologous Biologics Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Autologous Biologics Average Price (US$/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Autologous Biologics, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Autologous Biologics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Autologous Biologics, Product Type & Application
Table 12. Global Key Manufacturers of Autologous Biologics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autologous Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Biologics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autologous Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Autologous Biologics Sales by Region (2018-2023) & (Kg)
Table 18. Global Autologous Biologics Sales Market Share by Region (2018-2023)
Table 19. Global Autologous Biologics Sales by Region (2024-2029) & (Kg)
Table 20. Global Autologous Biologics Sales Market Share by Region (2024-2029)
Table 21. Global Autologous Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Autologous Biologics Revenue Market Share by Region (2018-2023)
Table 23. Global Autologous Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Autologous Biologics Revenue Market Share by Region (2024-2029)
Table 25. North America Autologous Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 27. North America Autologous Biologics Sales by Country (2024-2029) & (Kg)
Table 28. North America Autologous Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Autologous Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Autologous Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 32. Europe Autologous Biologics Sales by Country (2024-2029) & (Kg)
Table 33. Europe Autologous Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Autologous Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Autologous Biologics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Autologous Biologics Sales by Region (2018-2023) & (Kg)
Table 37. Asia Pacific Autologous Biologics Sales by Region (2024-2029) & (Kg)
Table 38. Asia Pacific Autologous Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Autologous Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Autologous Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 42. Latin America Autologous Biologics Sales by Country (2024-2029) & (Kg)
Table 43. Latin America Autologous Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Autologous Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Autologous Biologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 47. Middle East & Africa Autologous Biologics Sales by Country (2024-2029) & (Kg)
Table 48. Middle East & Africa Autologous Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Autologous Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Autologous Biologics Sales (Kg) by Type (2018-2023)
Table 51. Global Autologous Biologics Sales (Kg) by Type (2024-2029)
Table 52. Global Autologous Biologics Sales Market Share by Type (2018-2023)
Table 53. Global Autologous Biologics Sales Market Share by Type (2024-2029)
Table 54. Global Autologous Biologics Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Autologous Biologics Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Autologous Biologics Revenue Market Share by Type (2018-2023)
Table 57. Global Autologous Biologics Revenue Market Share by Type (2024-2029)
Table 58. Global Autologous Biologics Price (US$/Kg) by Type (2018-2023)
Table 59. Global Autologous Biologics Price (US$/Kg) by Type (2024-2029)
Table 60. Global Autologous Biologics Sales (Kg) by Application (2018-2023)
Table 61. Global Autologous Biologics Sales (Kg) by Application (2024-2029)
Table 62. Global Autologous Biologics Sales Market Share by Application (2018-2023)
Table 63. Global Autologous Biologics Sales Market Share by Application (2024-2029)
Table 64. Global Autologous Biologics Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Autologous Biologics Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Autologous Biologics Revenue Market Share by Application (2018-2023)
Table 67. Global Autologous Biologics Revenue Market Share by Application (2024-2029)
Table 68. Global Autologous Biologics Price (US$/Kg) by Application (2018-2023)
Table 69. Global Autologous Biologics Price (US$/Kg) by Application (2024-2029)
Table 70. Vericel Corporation Corporation Information
Table 71. Vericel Corporation Description and Business Overview
Table 72. Vericel Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 73. Vericel Corporation Autologous Biologics Product
Table 74. Vericel Corporation Recent Developments/Updates
Table 75. BioTime, Inc. Corporation Information
Table 76. BioTime, Inc. Description and Business Overview
Table 77. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 78. BioTime, Inc. Autologous Biologics Product
Table 79. BioTime, Inc. Recent Developments/Updates
Table 80. Pharmicell Co. Corporation Information
Table 81. Pharmicell Co. Description and Business Overview
Table 82. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 83. Pharmicell Co. Autologous Biologics Product
Table 84. Pharmicell Co. Recent Developments/Updates
Table 85. BrainStorm Cell Therapeutics Corporation Information
Table 86. BrainStorm Cell Therapeutics Description and Business Overview
Table 87. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 88. BrainStorm Cell Therapeutics Autologous Biologics Product
Table 89. BrainStorm Cell Therapeutics Recent Developments/Updates
Table 90. Opexa Therapeutics, Inc Corporation Information
Table 91. Opexa Therapeutics, Inc Description and Business Overview
Table 92. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 93. Opexa Therapeutics, Inc Autologous Biologics Product
Table 94. Opexa Therapeutics, Inc Recent Developments/Updates
Table 95. Pharmicell Co., Inc Corporation Information
Table 96. Pharmicell Co., Inc Description and Business Overview
Table 97. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 98. Pharmicell Co., Inc Autologous Biologics Product
Table 99. Pharmicell Co., Inc Recent Developments/Updates
Table 100. Neostem Corporation Information
Table 101. Neostem Description and Business Overview
Table 102. Neostem Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 103. Neostem Autologous Biologics Product
Table 104. Neostem Recent Developments/Updates
Table 105. Dendreon Corporation Corporation Information
Table 106. Dendreon Corporation Description and Business Overview
Table 107. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 108. Dendreon Corporation Autologous Biologics Product
Table 109. Dendreon Corporation Recent Developments/Updates
Table 110. Regenexx Corporation Information
Table 111. Regenexx Description and Business Overview
Table 112. Regenexx Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 113. Regenexx Autologous Biologics Product
Table 114. Regenexx Recent Developments/Updates
Table 115. Cytori Therapeutics Corporation Information
Table 116. Cytori Therapeutics Description and Business Overview
Table 117. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 118. Cytori Therapeutics Autologous Biologics Product
Table 119. Cytori Therapeutics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Autologous Biologics Distributors List
Table 123. Autologous Biologics Customers List
Table 124. Autologous Biologics Market Trends
Table 125. Autologous Biologics Market Drivers
Table 126. Autologous Biologics Market Challenges
Table 127. Autologous Biologics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Autologous Biologics
Figure 2. Global Autologous Biologics Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Autologous Biologics Market Share by Type in 2022 & 2029
Figure 4. Adipose Tissue Product Picture
Figure 5. Plasma Product Picture
Figure 6. Others Product Picture
Figure 7. Global Autologous Biologics Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Autologous Biologics Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Ambulatory Centers
Figure 11. Research Centers
Figure 12. Global Autologous Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Autologous Biologics Market Size (2018-2029) & (US$ Million)
Figure 14. Global Autologous Biologics Sales (2018-2029) & (Kg)
Figure 15. Global Autologous Biologics Average Price (US$/Kg) & (2018-2029)
Figure 16. Autologous Biologics Report Years Considered
Figure 17. Autologous Biologics Sales Share by Manufacturers in 2022
Figure 18. Global Autologous Biologics Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Autologous Biologics Players: Market Share by Revenue in 2022
Figure 20. Autologous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Autologous Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Autologous Biologics Sales Market Share by Country (2018-2029)
Figure 23. North America Autologous Biologics Revenue Market Share by Country (2018-2029)
Figure 24. United States Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Autologous Biologics Sales Market Share by Country (2018-2029)
Figure 27. Europe Autologous Biologics Revenue Market Share by Country (2018-2029)
Figure 28. Germany Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Autologous Biologics Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Autologous Biologics Revenue Market Share by Region (2018-2029)
Figure 35. China Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Autologous Biologics Sales Market Share by Country (2018-2029)
Figure 45. Latin America Autologous Biologics Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Autologous Biologics Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Autologous Biologics Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Autologous Biologics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Autologous Biologics by Type (2018-2029)
Figure 55. Global Revenue Market Share of Autologous Biologics by Type (2018-2029)
Figure 56. Global Autologous Biologics Price (US$/Kg) by Type (2018-2029)
Figure 57. Global Sales Market Share of Autologous Biologics by Application (2018-2029)
Figure 58. Global Revenue Market Share of Autologous Biologics by Application (2018-2029)
Figure 59. Global Autologous Biologics Price (US$/Kg) by Application (2018-2029)
Figure 60. Autologous Biologics Value Chain
Figure 61. Autologous Biologics Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 非筋層浸潤性膀胱がん治療薬の世界市場2023年：膀胱内化学療法、膀胱内免疫療法
  • 生物工学による代用皮膚の世界市場2023年：同種無細胞、異種、同種細胞、自家細胞
  • CD47（IAP）の世界市場インサイト・予測（～2028年）
  • 神経変性疾患の遺伝子治療のグローバル市場展望 2023年-2029年：遺伝子置換療法、遺伝子サイレンシング療法、遺伝子編集療法、酵素置換療法
  • 地図状萎縮の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7646 )"自家生物製剤の世界市場2023年：脂肪組織、血漿、その他" (英文：Global Autologous Biologics Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。